ALK inhibitors and advanced non-small cell lung cancer (Review)

By                  

International Journal of Oncology, Vol. 45, Iss. 2, 2014-01 ,pp. : 499-508

Spandidos Publications

Access to resources Recommend Favorite

ALK Status Assessment with Liquid Biopsies of Lung Cancer Patients

By Hofman Paul  

Cancers, Vol. 9, Iss. 8, 2017-08 ,pp. : 106-106

MDPI

Access to resources Recommend Favorite

Activated MET acts as a salvage signal after treatment with alectinib, a selective ALK inhibitor, in ALK-positive non-small cell lung cancer

By  

International Journal of Oncology, Vol. 46, Iss. 3, 2015-03 ,pp. : 1025-1030

Spandidos Publications

Access to resources Recommend Favorite

Hypoxia induces resistance to ALK inhibitors in the H3122 non-small cell lung cancer cell line with an ALK rearrangement via epithelial-mesenchymal transition

By                          

International Journal of Oncology, Vol. 45, Iss. 4, 2014-01 ,pp. : 1430-1436

Spandidos Publications

Access to resources Recommend Favorite

A case of ALK-associated non-small-cell lung cancer with evidence of omental metastasis 6 years after initial presentation

By Kulkarni Sameer   Kabbinavar Fairooz   Eshaghian Shahrooz  

Lung Cancer Management, Vol. 2, Iss. 3, 2013-06 ,pp. : 199-204

Future Medicine

Access to resources Recommend Favorite